79323511 - HINYE PHARMA

Information

• Trademark
• 79323511

• Source

• Serial Number

  79323511

• Registration Number

  6805693

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  June 28, 2021
  3 years ago

• Registration Date

  August 02, 2022
  2 years ago

• Transaction Date

  October 02, 2022
  2 years ago

• Status Date

  August 02, 2022
  2 years ago

• Published for Opposition Date

  May 17, 2022
  2 years ago

• Location Date

  August 02, 2022
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  HELLMAN, ELI J

• Law Office Assigned Location Code

  L20

• Owners

  • HINYE PHARMACEUTICAL CO., LTD.

Case File Statements

• DM0000: The design element appearing to the left of the Chinese characters and wording is comprised of a diamond embedded with a notch and a long curved line. To the right of the design element appears four Chinese characters in horizontal arrangement above the wording HINYE PHARMACY.
• GS0051: Herbal supplements; medicinal herbal preparations; medicinal herbs; herbs for medicinal purposes; Chinese traditional medicinal herbs; medicinal herbal extracts for medical purposes; medicines for the treatment of gastrointestinal diseases; anti-allergic medicines; medicines for alleviating constipation; pharmaceutical preparations for the treatment of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; pharmaceutical preparations for the prevention of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammatory disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; chemical preparations for pharmaceutical or medical purposes, namely, for cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; unit dose capsules sold empty for pharmaceutical use; biological preparations for the treatment of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; allergy tablets; antibiotic tablets
• TLIT00: The transliteration of the non-Latin characters in the mark is Tian Di Heng YI.
• TR0010: The four Chinese characters Tian Di Heng YI are translated as HINYE. The Chinese characters in the mark and the wording HINYE have no meaning in English.
• D10000: "PHARMA"

Case File Event Statements

• 10/2/2022 - 2 years ago

  16 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 9/15/2022 - 2 years ago

  15 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 9/15/2022 - 2 years ago

  14 - FINAL DISPOSITION PROCESSED Type: FIMP

• 9/1/2022 - 2 years ago

  13 - GRANT OF PROTECTION CREATED, TO BE SENT TO IB Type: GPAR

• 8/2/2022 - 2 years ago

  12 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 5/17/2022 - 2 years ago

  11 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/16/2022 - 2 years ago

  10 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 4/27/2022 - 2 years ago

  9 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 4/27/2022 - 2 years ago

  8 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 4/27/2022 - 2 years ago

  7 - NOTICE OF PUBLICATION Type: NPUB

• 4/10/2022 - 2 years ago

  6 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/18/2022 - 2 years ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 11/6/2021 - 3 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 11/2/2021 - 3 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 10/30/2021 - 3 years ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 10/22/2021 - 3 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR